Jasper Therapeutics, Inc.
JSPRNasdaqCIK 1788028HealthcareFiscal year ends Dec 31
Reports and events: 144 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-04-2916:01 ET | DEF 14A | Proxy statementPeriod 2022-06-23 | 0001213900-22-022704 |
| 2022-04-2716:01 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-021894 |
| 2022-03-2108:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-013743 |
| 2022-03-1816:16 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001213900-22-013592 |
| 2022-03-1816:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-013584 |
| 2022-03-1616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-22-012935 |
| 2022-03-1606:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-012682 |
| 2022-03-1116:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-22-011854 |
| 2022-02-2808:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-009585 |
| 2022-02-2519:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-22-009272 |
| 2021-11-1216:04 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001213900-21-058660 |
| 2021-11-1216:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-21-058658 |
| 2021-10-2916:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-21-055431 |
| 2021-10-1818:08 ET | S-1 | Registration statement | 0001213900-21-053099 |
| 2021-10-0416:10 ET | SC 13D | Ownership report, active investor | 0000905718-21-001266 |
| 2021-09-2916:46 ET | 8-K/A | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001213900-21-050602 |
| 2021-09-2916:37 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.06 Item not in the standard list; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-050592 |
| 2021-09-2320:38 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-049423 |
| 2021-09-2016:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-048846 |
| 2021-09-0916:34 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-047217 |
| 2021-08-1617:04 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001213900-21-043115 |
| 2021-07-2320:39 ET | 10-Q/A | Quarterly report, amendedPeriod 2021-03-31 | 0001213900-21-038236 |
| 2021-07-1919:02 ET | 10-Q/A | Quarterly report, amendedPeriod 2021-03-31 | 0001213900-21-037317 |
| 2021-07-1919:00 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-037315 |
| 2021-05-2416:20 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001213900-21-028790 |
| 2021-05-2416:14 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001213900-21-028779 |
| 2021-05-1816:18 ET | 8-K | 4.02 Non-reliance on financial statements | 0001213900-21-027626 |
| 2021-05-0716:07 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-21-025120 |
| 2021-05-0608:59 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-21-024792 |
| 2021-03-3017:00 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001213900-21-018735 |
| 2020-12-2906:12 ET | 8-K | 5.07 Shareholder vote results | 0001213900-20-045061 |
| 2020-12-0417:20 ET | DEF 14A | Proxy statementPeriod 2020-12-22 | 0001213900-20-041132 |
| 2020-12-0312:08 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events | 0001213900-20-040662 |
| 2020-11-1017:19 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001213900-20-036217 |
| 2020-08-1420:30 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001213900-20-022013 |
| 2020-05-1317:12 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001213900-20-012038 |
| 2020-03-2616:14 ET | 10-K | Annual reportPeriod 2019-12-31 | 0001213900-20-007505 |
| 2020-01-0808:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-20-000455 |
| 2019-11-2716:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-024928 |
| 2019-11-2516:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-19-024606 |
| 2019-11-1417:22 ET | S-1/A | Registration statement, amended | 0001213900-19-023556 |
| 2019-11-0816:29 ET | S-1/A | Registration statement, amended | 0001213900-19-022572 |
| 2019-11-0616:45 ET | S-1/A | Registration statement, amended | 0001213900-19-022224 |
| 2019-10-2516:10 ET | S-1 | Registration statement | 0001213900-19-021144 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 9, 2026, 17:50 ET. Listed shows no prices and gives no investment advice.